title: Severe hemolytic anemia due to cold agglutinin complicating untreated chronic hepatitis C: efficacy and safety of anti-CD20 (rituximab) treatment.
abstract: Autoimmune hemolytic anemia (AIHA) is rare and difficult to treat during chronic hepatitis C. We report herein the case of a hepatitis C patient with severe and resistant AIHA who experienced a good and sustained response with anti-CD20 monoclonal antibody treatment.
authors.affiliation: Service de Médecine Interne, Hôpital de la Conception, Marseille, France.
authors.forename: Anne
authors.initials: A
authors.lastname: Etienne
authors.forename: Stéphane
authors.initials: S
authors.lastname: Gayet
authors.forename: Florian
authors.initials: F
authors.lastname: Vidal
authors.forename: Pascale
authors.initials: P
authors.lastname: Poullin
authors.forename: Corinne
authors.initials: C
authors.lastname: Brunet
authors.forename: Jean-Robert
authors.initials: JR
authors.lastname: Harlé
authors.forename: Gilles
authors.initials: G
authors.lastname: Kaplanski
mesh_terms: D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000097:blood / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D018951:Antigens, CD20 / Q000009:adverse effects / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000097:blood / Q000150:complications*; D006801:Humans; D008297:Male; D016896:Treatment Outcome
chemical_list: D018951:Antigens, CD20